Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cellectis (CLLS) Current Assets (2016 - 2025)

Cellectis (CLLS) has 8 years of Current Assets data on record, last reported at $122.0 million in Q4 2022.

  • For Q4 2022, Current Assets rose 177.91% year-over-year to $122.0 million; the TTM value through Dec 2022 reached $122.0 million, changed N/A, while the annual FY2022 figure was $122.0 million, 177.91% up from the prior year.
  • Current Assets reached $122.0 million in Q4 2022 per CLLS's latest filing, up from -$156.6 million in the prior quarter.
  • Across five years, Current Assets topped out at $487.6 million in Q4 2018 and bottomed at -$156.6 million in Q4 2021.
  • Average Current Assets over 4 years is $74.7 million, with a median of -$16.0 million recorded in 2020.
  • Peak YoY movement for Current Assets: fell 1.65% in 2021, then skyrocketed 177.91% in 2022.
  • A 4-year view of Current Assets shows it stood at $487.6 million in 2018, then crashed by 131.6% to -$154.1 million in 2020, then fell by 1.65% to -$156.6 million in 2021, then skyrocketed by 177.91% to $122.0 million in 2022.
  • Per Business Quant database, its latest 3 readings for Current Assets were $122.0 million in Q4 2022, -$156.6 million in Q4 2021, and -$154.1 million in Q4 2020.